文献速递重症综合管理与镇静镇痛

序贯器官衰竭评估(SOFA)-2评分的开发与验证

Development and Validation of the Sequential Organ Failure Assessment (SOFA)-2 Score.
PubMed 文献 · JAMA · 2025-01-01
一句话结论SOFA-2在1319个ICU、334万例成人重症患者中开发并验证,纳入当代器官支持治疗并修订阈值,ICU首日AUROC为0.79(95%CI 0.76-0.81),高于SOFA-1的0.77(95%CI 0.74-0.81)。

SOFA评分30年未更新,可能无法反映当前临床实践与结局。该研究在9个国家1319个ICU的成人患者中,经改良Delphi流程确定内容效度后,用4个多中心队列(2 098 356例)开发并内部验证SOFA-2,另用6个队列(1 241 114例)外部验证。SOFA-2修改了原SOFA的6个器官系统(脑、呼吸、心血管、肝、肾、止血),纳入新变量并修订阈值以更好描述0至4分的器官功能障碍分布及其相关死亡;ICU首日AUROC为0.79(95%CI 0.76-0.81),SOFA-1为0.77(95%CI 0.74-0.81),ICU第1至7天的序贯SOFA-2数据维持预测效度。因数据不足和缺乏内容效度,胃肠与免疫功能障碍评分未纳入SOFA-2。

要点

  • SOFA-2在9国1319个ICU的成人患者中开发验证,ICU首日AUROC 0.79(95%CI 0.76-0.81),SOFA-1为0.77(95%CI 0.74-0.81)。
  • SOFA-2修改原SOFA的6个器官系统(脑、呼吸、心血管、肝、肾、止血),纳入新变量和修订阈值以描述0至4分器官功能障碍分布及相关死亡。
  • ICU第1至7天的序贯SOFA-2数据维持预测效度。
  • 因数据不足和缺乏内容效度,胃肠和免疫功能障碍评分未纳入SOFA-2。
  • 10个队列共3.34百万例患者,270 108例(8.1%)死于ICU,各队列范围4.5%至20.5%。

适用人群与场景

  • 9个国家(澳大利亚、奥地利、巴西、法国、意大利、日本、尼泊尔、新西兰、美国)1319个ICU收治的成人患者,数据收集于2014至2023年。
  • 开发与内部验证用4个代表性多中心队列共2 098 356例患者;外部验证用6个队列共1 241 114例患者。

诊断标准与关键阈值

  • SOFA-2修改原SOFA的6个器官系统(脑、呼吸、心血管、肝、肾、止血),纳入新变量并修订阈值,以更好描述0至4分的器官功能障碍分布及其相关死亡。
  • 评分在ICU首日测量,评分越高表示器官功能障碍越重。

研究设计与关键结果

  • 研究类型为联邦式分析,开发并验证SOFA-2评分;开发与内部验证用4个多中心队列2 098 356例,外部验证用6个队列1 241 114例,共3.34百万例患者。
  • 10个队列中270 108例(8.1%)死于ICU,各队列ICU死亡率范围4.5%至20.5%。
  • ICU首日SOFA-2的AUROC为0.79(95%CI 0.76-0.81),SOFA-1的AUROC为0.77(95%CI 0.74-0.81)。
  • 评估ICU第1天至第7天的序贯SOFA-2数据,维持其预测效度。
  • 因数据不足和缺乏内容效度,胃肠和免疫功能障碍评分未能纳入SOFA-2。

证据类型、等级与局限

  • 证据类型:联邦式分析(评分开发与验证研究),经改良Delphi流程(第1至5阶段)确定内容效度后开展数据驱动开发(第6至8阶段)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • SOFA-2纳入了当代器官支持治疗并修订评分阈值,可在ICU首日及第1至7天序贯评估成人重症患者的器官功能障碍,其预测效度在大型、地理和社会经济多样的人群中得到验证。
  • 因数据不足和缺乏内容效度,SOFA-2未纳入胃肠和免疫功能障碍评分。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Acute dysfunction of vital organs is the hallmark of critical illness. The Sequential Organ Failure Assessment (SOFA) score, the most widely adopted approach to describe organ dysfunction, has not been updated in 30 years and therefore may not appropriately capture current clinical practice and outcomes.

OBJECTIVES: To inform the data-driven component of an updated score (SOFA-2) in varied geographical and resource settings (stages 6-8) after expert input via a modified Delphi process (stages 1-5).

DESIGN, SETTING, AND PARTICIPANTS: A federated analysis was performed on data collected from adult patients admitted to 1319 intensive care units (ICUs) in 9 countries (Australia, Austria, Brazil, France, Italy, Japan, Nepal, New Zealand, United States) between 2014 and 2023. Four representative multicenter cohorts containing data from 2 098 356 patients were used for data-driven score development and internal validation. External validation was performed on 6 cohorts containing data from 1 241 114 patients.

MAIN OUTCOMES AND MEASURES: Content validity for organ dysfunction identified through the modified Delphi process should be reflected by predictive validity using the area under the receiver operating characteristic (AUROC) curve of the score measured on the first ICU day (higher scores indicate worse organ dysfunction).

RESULTS: Of 3.34 million patient encounters, 270 108 (8.1%) died in the ICU (range, 4.5% to 20.5% across the 10 cohorts). SOFA-2 modified the 6 organ systems of the original SOFA score (brain, respiratory, cardiovascular, liver, kidney, hemostasis), including new variables and revised thresholds that better describe the organ dysfunction distribution from 0 to 4 points and their associated mortality (SOFA-2 AUROC, 0.79; 95% CI, 0.76-0.81; SOFA-1 AUROC, 0.77; 95% CI, 0.74-0.81). Evaluation of sequential SOFA-2 data from ICU day 1 to day 7 maintained its predictive validity. Insufficient data and lack of content validity precluded incorporation of gastrointestinal and immune dysfunction scores into SOFA-2.

CONCLUSIONS AND RELEVANCE: The SOFA-2 score, updated to include contemporary organ support treatments and new score thresholds, describes organ dysfunction in a large, geographically and socioeconomically diverse population of critically ill adults.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Ranzani OT, Singer M, Salluh JIF, et al. Development and Validation of the Sequential Organ Failure Assessment (SOFA)-2 Score. JAMA. 2025. PMID: 41159833. doi:10.1001/jama.2025.20516

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。